Intravenous immunoglobulin therapy is not able to efficiently control cutaneous manifestations in patients with lupus erythematosus
- 1 May 1997
- journal article
- other
- Published by SAGE Publications in Lupus
- Vol. 6 (4) , 415-417
- https://doi.org/10.1177/096120339700600414
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- High-dose intravenous immunoglobulins for immediate control of severe pemphigus vulgarisBritish Journal of Dermatology, 1995
- CURRENT RHEUMATOLOGICAL USES OF INTRAVENOUS IMMUNOGLOBULINRheumatology, 1994
- Juvenile dermatomyositis: treatment with intravenous gammaglobulinBritish Journal of Dermatology, 1994
- Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20 adult patientsThe American Journal of Medicine, 1991
- Improvement of Histological and Immunological Change in Steroid and Immunosuppressive Drug-Resistant Lupus nephritis by High-Dose Intravenous Gamma GlobulinNephron, 1989